Consequently, various groups have developed strategies to overexpress SDF-1 mRNA or deliver SDF-1 protein after acute myocardial infarction in the heart to attenuate ischemic cardiomyopathy [7–9]. This evidence concerns the gene CXCL12 and acute myocardial infarction.